Deliberations in Martin Shkreli trial to enter 3rd day


6 photos

Estimated read time: Less than a minute

This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in its archived form does not constitute a republication of the story.

NEW YORK (AP) — Jurors have deliberated for a second day at the federal securities fraud trial of former pharmaceutical company CEO Martin Shkreli (SHKREL'-ee).

They got the case Monday in New York and spent a full day deliberating Tuesday before ending the day without a verdict. Deliberations resume Wednesday.

Prosecutors say Shkreli looted his drug company to pay back investors in two failed hedge funds he ran. The defense says investors got their original investments back and even made hefty profits.

The former biotech CEO — nicknamed "Pharma Bro" — is best known for hiking up the price of a life-saving drug and for trolling his critics on social media.

If convicted of the most serious counts, he could face up to 20 years in prison but likely would receive far less time under sentencing guidelines.

Copyright © The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Photos

Most recent Business stories

Related topics

Business
The Associated Press

    SIGN UP FOR THE KSL.COM NEWSLETTER

    Catch up on the top news and features from KSL.com, sent weekly.
    By subscribing, you acknowledge and agree to KSL.com's Terms of Use and Privacy Policy.

    KSL Weather Forecast